Related Experiment Video
Updated: May 22, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
High prevalence of elevated lead levels in pediatric dialysis patients
Guido Filler1, Elizabeth Roach, Abeer Yasin
1Department of Pediatrics, Schulich School of Medicine & Dentistry, London, ON, Canada. guido.filler@lhsc.on.ca
Insights
Pediatric chronic kidney disease (CKD) patients on calcium carbonate treatment showed elevated blood lead (Pb) levels. Monitoring lead is crucial for these vulnerable patients.
Area of Science:
- Nephrology
- Environmental Health
- Pediatric Medicine
Background:
- Concerns arose regarding lead (Pb) contamination in calcium carbonate used for hyperphosphatemia treatment in pediatric chronic kidney disease (CKD).
- A quality-assurance investigation was conducted to measure blood Pb levels in pediatric CKD patients.
Purpose of the Study:
- To assess blood lead levels in pediatric patients with chronic kidney disease (CKD).
- To investigate the correlation between lead levels, kidney function, and calcium carbonate dosage.
Main Methods:
- Blood lead (Pb) levels were measured using high-resolution sector field inductively coupled mass spectrometry.
- Kidney function was assessed via cystatin C estimated glomerular filtration rate (eGFR).
- Lead levels in dialysis feed water were also analyzed.
Main Results:
- Pediatric CKD patients exhibited significantly higher mean blood Pb concentrations (21.1 ± 15.8 µg/l) compared to healthy controls.
- Elevated lead levels correlated with red blood cell distribution width, eGFR, and calcium carbonate dose.
- Lead levels in dialysis feed water were below the accepted limit.
Conclusions:
- A high prevalence of elevated blood lead levels was found in pediatric CKD patients.
- Lead levels were correlated with calcium carbonate dose and glomerular filtration rate (GFR).
- Routine monitoring of lead levels is recommended for pediatric CKD patients.
Background:
After parents raised concerns about potential lead (Pb) contamination of calcium carbonate for treatment of hyperphosphatemia in chronic kidney disease (CKD), we measured blood Pb using high-resolution sector field inductively coupled mass spectrometry in a quality-assurance investigation of ten pediatric dialysis patients (nine on hemodialysis) and six patients before dialysis.
Methods:
We assessed the kidney function as cystatin C estimated glomerular filtration rate (eGFR), blood Pb levels, calcium carbonate dose, and standard laboratory parameters, as well as Pb levels in the dialysis feed water.
Results:
Mean blood Pb concentration in the 16 pediatric CKD patients was 21.1 ± 15.8 µg/l with a maximum of 58 µg/l, which was significantly higher than that of 467 apparently healthy controls (median 6.35 µg/l, interquartile range 4.47, 8.71) and comparable to that of ten adult peritoneal dialysis (PD) patients. Lead levels correlated with red blood cell distribution width, eGFR, and calcium carbonate dose. Pb in dialysate feed water was always <0.00018 mg/l, which is below the accepted limit for water for dialysis of 0.005 mg/l.
Conclusions:
We found a high prevalence of elevated Pb levels in pediatric CKD patients that correlated with the calcium carbonate dose and GFR. Lead levels should be monitored in these patients.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Peritoneal Dialysis III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Chronic Kidney Disease II: Clinical Manifestations
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
